FXIII-mediated down-regulation of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in venous ulcers

被引：0
|
作者：
Hellstern, MO [1 ]
Norgauer, J [1 ]
Schöpf, E [1 ]
Herouy, Y [1 ]
机构：
[1] Univ Hosp, Dept Dermatol, Freiberg, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
020
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [1] The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis
    Herouy, Y
    Aizpurua, J
    Stetter, C
    Dichmann, S
    Idzko, M
    Hofmann, C
    Gitsch, G
    Vanscheidt, W
    Schöpf, E
    Norgauer, J
    JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (06) : 291 - 297
  • [2] Elevated expression of CD87 and its ligand urokinase-type plasminogen activator (uPA) in lipodermatosclerosis
    Herouy, Y
    Stetter, C
    May, AE
    Schopf, E
    Vanscheidt, W
    Norgauer, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 599 - 599
  • [3] Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87)
    Schaefer, BM
    Reinartz, J
    Bechtel, MJ
    Inndorf, S
    Lang, E
    Kramer, MD
    EXPERIMENTAL CELL RESEARCH, 1996, 228 (02) : 246 - 253
  • [4] CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review
    M C Béné
    G Castoldi
    W Knapp
    G M Rigolin
    L Escribano
    P Lemez
    W-D Ludwig
    E Matutes
    A Orfao
    F Lanza
    M van't Veer
    Leukemia, 2004, 18 : 394 - 400
  • [5] CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders:: a review
    Béné, MC
    Castoldi, G
    Knapp, W
    Rigolin, GM
    Escribano, L
    Lemez, P
    Ludwig, WD
    Matutes, E
    Orfao, A
    Lanza, F
    van't Veer, M
    LEUKEMIA, 2004, 18 (03) : 394 - 400
  • [6] Expression and functional role of urokinase-type plasminogen activator receptor (UPA-R; CD87) in normal and acute leukemia cells
    Castagnari, B
    Moretti, S
    Latorraca, A
    Spisani, S
    Traniello, S
    Castoldi, GL
    Lanza, F
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1997, 41 : 109 - 110
  • [7] The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule
    Dear, AE
    Medcalf, RL
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 252 (02): : 185 - 193
  • [8] Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)
    Longstaff, C
    Merton, RE
    Fabregas, P
    Felez, J
    BLOOD, 1999, 93 (11) : 3839 - 3846
  • [9] The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule
    Dear, A. E.
    Medcalf, R. L.
    European Journal of Biochemistry, 252 (02):
  • [10] Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay
    Goretzki, L
    Bognacki, J
    Koppitz, M
    Rettenberger, P
    Magdolen, V
    Creutzburg, S
    Hammelburger, J
    Weidle, UH
    Wilhelm, O
    Kessler, H
    Graeff, H
    Schmitt, M
    FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (01): : 11 - 19
12345